JPMorgan Chase & Co. Lowers Immunocore (NASDAQ:IMCR) Price Target to $50.00
Immunocore (NASDAQ:IMCR – Get Free Report) had its price target dropped by research analysts at JPMorgan Chase & Co. from $54.00 to $50.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 83.08% from the […]
Immunocore (NASDAQ:IMCR – Get Free Report) had its price target dropped by research analysts at JPMorgan Chase & Co. from $54.00 to $50.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 83.08% from the […]
